Sort
15,273 grants matching “antimicrobial resistance”
TARGETED CLINICAL TRIALS TO REDUCE THE RISK OF ANTIMICROBIAL RESISTANCE
$8,509,190Keith Kaye · University Of Michigan At Ann Arbor · N01 · FY2017 · AI
STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH ON RESISTANT BACTERIA
$8,114,134Marian Ewell · The Emmes Company, Llc · N01 · FY2018 · AI
Statistical and Data Coordinating Center (SDCC): Antibacterial Resistance Clinical Research Activities
$8,000,000Marian Ewell · The Emmes Company, Llc · N01 · FY2025 · AI
Statistical and Data Coordinating Center: Antibacterial Resistance Studies
$8,000,000Marian Ewell · The Emmes Company, Llc · N01 · FY2024 · AI
Antibacterial Resistance Leadership Group (ARLG)
$8,000,000Vance G Fowler · Duke University · UM1 · FY2017 · AI
Center for accelerated development of drug candidates targeting high threat bacterial infections
$7,562,521David S Perlin · Hackensack University Medical Center · U19 · FY2025 · AI
GH21-003, Advancing Public Health Research in Kenya
$7,500,000M Kariuki Njenga · Washington State University · U01 · FY2023 · GH
GH21-003, Advancing Public Health Research in Kenya
$7,426,960M Kariuki Njenga · Washington State University · U01 · FY2022 · GH
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2023 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2022 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2020 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2021 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Beth C Levine · Ut Southwestern Medical Center · U19 · FY2019 · AI
GH16-006: Conducting Communicable Disease Research in Kenya
$7,379,978M Kariuki Njenga · Washington State University · U01 · FY2018 · GH
The Infectious Diseases Clinical Research Program (IDCRP)
$7,098,800National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI
CLINICAL TRIAL FOR COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREU
$7,084,685University Of California, San Francisco · N01 · FY2011 · AI
Innovative technologies to transform antibiotic discovery.
$7,082,911Deborah T Hung · Broad Institute, Inc. · U19 · FY2019 · AI
GH16-006: Conducting Communicable Disease Research in Kenya
$7,082,048M Kariuki Njenga · Washington State University · U01 · FY2017 · GH
Innovative technologies to transform antibiotic discovery.
$6,944,328Deborah T Hung · Broad Institute, Inc. · U19 · FY2020 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
$6,880,060David S Perlin · Hackensack University Medical Center · U19 · FY2019 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$6,820,430Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2021 · AI
Innovative technologies to transform antibiotic discovery.
$6,735,434Deborah T Hung · Broad Institute, Inc. · U19 · FY2021 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
$6,639,071David S Perlin · Hackensack University Medical Center · U19 · FY2021 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
$6,638,250David S Perlin · Hackensack University Medical Center · U19 · FY2022 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
$6,638,108David S Perlin · Hackensack University Medical Center · U19 · FY2020 · AI